Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$654M |
| 2 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$241M |
| 3 |
iShares Gold Trust
IAU
|
+$232M |
| 4 |
VanEck Oil Services ETF
OIH
|
+$200M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Carvana
CVNA
|
+$540M |
| 4 |
Target
TGT
|
+$430M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.49% |
| 2 | Financials | 5.96% |
| 3 | Consumer Discretionary | 5.3% |
| 4 | Healthcare | 4.99% |
| 5 | Communication Services | 3.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Coupang
CPNG
$29.3B
| $1.39M | ﹤0.01% |
78,576
-182,410
| -70% | -$3.9M |
|
2627
Veracyte
VCYT
$3.7B
| $1.39M | ﹤0.01% |
50,375
-80,229
| -61% | -$2.29M |
|
|
GSQB
2628
DELISTED
G Squared Ascend II Inc.
GSQB
| $1.39M | ﹤0.01% |
+141,493
| New | +$1.38M |
|
2629
Amphastar Pharmaceuticals
AMPH
$879M
| $1.39M | ﹤0.01% |
38,664
+8,224
| +27% | +$233K |
|
2630
iShares US Medical Devices ETF
IHI
$3.13B
| $1.39M | ﹤0.01% |
22,756
-26,147
| -53% | -$1.56M |
|
2631
Monro
MNRO
$383M
| $1.39M | ﹤0.01% |
31,255
+2,319
| +8% | +$113K |
|
2632
CEVA Inc
CEVA
$910M
| $1.39M | ﹤0.01% |
34,057
-140
| -0.4% | -$5.44K |
|
2633
PTC Therapeutics
PTCT
$5.68B
| $1.39M | ﹤0.01% |
37,116
-95,752
| -72% | -$3.69M |
|
2634
CALL
Las Vegas Sands
LVS
$31.7B
| $1.38M | ﹤0.01% |
35,600
+21,500
| +152% | +$892K |
|
2635
PUT
BHP
BHP
$215B
| $1.38M | ﹤0.01% |
20,066
-148,084
| -88% | -$9M |
|
2636
NBT Bancorp
NBTB
$2.74B
| $1.38M | ﹤0.01% |
38,245
+4,022
| +12% | +$156K |
|
2637
Andersons Inc
ANDE
$2.41B
| $1.38M | ﹤0.01% |
27,445
+2,418
| +10% | +$102K |
|
|
BBT
2638
Beacon Financial Corp
BBT
$2.66B
| $1.38M | ﹤0.01% |
47,577
+1,329
| +3% | +$40K |
|
2639
Patrick Industries
PATK
$2.74B
| $1.38M | ﹤0.01% |
34,277
+4,392
| +15% | +$203K |
|
2640
CALL
Bausch Health
BHC
$2.58B
| $1.38M | ﹤0.01% |
60,200
-379,700
| -86% | -$9.28M |
|
2641
Tennant Co
TNC
$1.43B
| $1.38M | ﹤0.01% |
17,460
+1,017
| +6% | +$80.3K |
|
2642
Tower Semiconductor
TSEM
$24.8B
| $1.38M | ﹤0.01% |
28,383
+9,882
| +53% | +$417K |
|
|
RXDX
2643
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.37M | ﹤0.01% |
+36,400
| New | +$1.44M |
|
|
DHR.PRA
2644
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $1.37M | ﹤0.01% |
677
+624
| +1,177% | +$1.18M |
|
2645
EnerSys
ENS
$6.78B
| $1.37M | ﹤0.01% |
18,346
-12,250
| -40% | -$915K |
|
2646
Gibraltar Industries
ROCK
$1.25B
| $1.37M | ﹤0.01% |
31,852
+3,456
| +12% | +$182K |
|
|
SLCA
2647
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.37M | ﹤0.01% |
73,258
+4,027
| +6% | +$50.9K |
|
2648
Interparfums
IPAR
$3.99B
| $1.36M | ﹤0.01% |
15,487
+1,412
| +10% | +$131K |
|
2649
Murphy USA
MUSA
$11.2B
| $1.36M | ﹤0.01% |
6,816
-4,854
| -42% | -$911K |
|
|
APLS
2650
DELISTED
Apellis Pharmaceuticals
APLS
| $1.36M | ﹤0.01% |
26,684
-93,004
| -78% | -$4.11M |
|
Similar funds
Citigroup's Q1 2022 Portfolio in Review
As of Q1 2022, Citigroup held 6,926 positions worth $165B, down 12% from $187B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup withdrew a net $11.2B in Q1 2022, closing 497 positions and reducing 3,025 holdings. Its most notable exit was Xilinx Inc, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in ProShares UltraPro Short QQQ worth $126M.
- Citigroup's largest Q1 2022 buy was ProShares UltraPro Short QQQ: 149,740 shares worth $126M.
- Citigroup added most to iShares Russell 2000 ETF in Q1 2022, an estimated $654M increase.
- Citigroup's biggest Q1 2022 reduction was Apple, cutting an estimated $852M.
- Citigroup fully exited Xilinx Inc in Q1 2022, selling an estimated $235M.
- Citigroup's ten largest holdings make up 28% of its $165B portfolio in Q1 2022.
- Citigroup opened 1,006 new positions and closed 497 in Q1 2022.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $165B.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.